APA (7th ed.) Citation

R, D., A, P., M, B., SK, H., VVVP, M., & SC, P. (2022). Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor: -an in silico and in vitro approach. Medical oncology (Northwood, London, England), 39(11), 179. https://doi.org/10.1007/s12032-022-01826-5

Chicago Style (17th ed.) Citation

R, Doneti, Pasha A, Botlagunta M, Heena SK, Mutyala VVVP, and Pawar SC. "Molecular Docking, Synthesis, and Biological Evaluation of 7-azaindole-derivative (7AID) as Novel Anti-cancer Agent and Potent DDX3 Inhibitor: -an in Silico and in Vitro Approach." Medical Oncology (Northwood, London, England) 39, no. 11 (2022): 179. https://doi.org/10.1007/s12032-022-01826-5.

MLA (9th ed.) Citation

R, Doneti, et al. "Molecular Docking, Synthesis, and Biological Evaluation of 7-azaindole-derivative (7AID) as Novel Anti-cancer Agent and Potent DDX3 Inhibitor: -an in Silico and in Vitro Approach." Medical Oncology (Northwood, London, England), vol. 39, no. 11, 2022, p. 179, https://doi.org/10.1007/s12032-022-01826-5.